Green Biologics Ltd
closedRenewable chemicals naturally designed to deliver the performance that adds value to everyday products.
Launch date
Employees
Market cap
-
Enterprise valuation
$168—252m (Dealroom.co estimates Jan 2015.)
Company register number 04358718
Abingdon England (HQ)
Financials
Estimates*
| EUR | 2015 | 2016 | 2017 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Revenues | 33.4m | 8.5m | 1.8m | 3.2m | <1m | - | - |
| % growth | 1685 % | (75 %) | (79 %) | - | (94 %) | - | - |
| EBITDA | (9.0m) | (12.3m) | (13.2m) | (73.3m) | 10.2m | (<1m) | (<1m) |
| % EBITDA margin | (27 %) | (145 %) | (730 %) | (2306 %) | 5316 % | - | - |
| Profit | (15.1m) | (17.3m) | (21.3m) | (89.5m) | (<1m) | 14.1m | (<1m) |
| % profit margin | (45 %) | (205 %) | (1177 %) | (2819 %) | (469 %) | - | - |
| R&D budget | 5.0m | 6.4m | 1.5m | 2.2m | - | - | - |
| R&D % of revenue | 15 % | 76 % | 81 % | 70 % | - | - | - |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
$3.2m | Series A | ||
| N/A | £1.0m | Early VC | |
| N/A | $6.1m | Series B | |
* | N/A | Support Program | |
| N/A | £3.2m | Early VC | |
£2.0m | Early VC | ||
£15.4m | Series B | ||
$42.0m | Series C | ||
| N/A | $34.0m | Debt | |
£330k | Grant | ||
N/A | Grant | ||
| Total Funding | $80.2m | ||
Recent News about Green Biologics Ltd
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.